Chevy Chase Trust Holdings Inc. boosted its stake in Cardinal Health, Inc. (NYSE:CAH) by 0.7% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 276,145 shares of the company’s stock after buying an additional 1,977 shares during the quarter. Chevy Chase Trust Holdings Inc. owned approximately 0.09% of Cardinal Health worth $18,480,000 at the end of the most recent reporting period.
A number of other institutional investors also recently modified their holdings of the stock. Bronfman E.L. Rothschild L.P. lifted its stake in Cardinal Health by 31.8% in the 2nd quarter. Bronfman E.L. Rothschild L.P. now owns 1,583 shares of the company’s stock worth $123,000 after purchasing an additional 382 shares in the last quarter. Advisory Services Network LLC lifted its stake in Cardinal Health by 18.4% in the 2nd quarter. Advisory Services Network LLC now owns 1,739 shares of the company’s stock worth $136,000 after purchasing an additional 270 shares in the last quarter. Dupont Capital Management Corp purchased a new position in Cardinal Health in the 2nd quarter worth approximately $164,000. First Personal Financial Services lifted its stake in Cardinal Health by 127.5% in the 2nd quarter. First Personal Financial Services now owns 2,209 shares of the company’s stock worth $172,000 after purchasing an additional 1,238 shares in the last quarter. Finally, Sun Life Financial INC lifted its stake in Cardinal Health by 16,228.6% in the 2nd quarter. Sun Life Financial INC now owns 2,286 shares of the company’s stock worth $178,000 after purchasing an additional 2,272 shares in the last quarter. 88.47% of the stock is currently owned by hedge funds and other institutional investors.
A number of research analysts have weighed in on the stock. Needham & Company LLC reissued a “hold” rating on shares of Cardinal Health in a research note on Sunday, September 10th. Jefferies Group set a $77.00 price target on shares of Cardinal Health and gave the stock a “hold” rating in a report on Tuesday, August 29th. Cowen upgraded shares of Cardinal Health to a “buy” rating and set a $74.00 price target for the company in a report on Tuesday, October 10th. Mizuho set a $70.00 price target on shares of Cardinal Health and gave the stock a “hold” rating in a report on Tuesday, October 24th. Finally, Robert W. Baird restated a “hold” rating and set a $73.00 price target on shares of Cardinal Health in a report on Sunday, September 17th. Two equities research analysts have rated the stock with a sell rating, thirteen have assigned a hold rating and five have issued a buy rating to the company’s stock. Cardinal Health has a consensus rating of “Hold” and a consensus target price of $73.91.
Cardinal Health (NYSE:CAH) last posted its quarterly earnings results on Monday, November 6th. The company reported $1.09 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.00 by $0.09. The business had revenue of $32.64 billion during the quarter, compared to the consensus estimate of $33.48 billion. Cardinal Health had a net margin of 0.84% and a return on equity of 25.24%. The company’s quarterly revenue was up 1.9% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.24 earnings per share. equities analysts expect that Cardinal Health, Inc. will post 4.97 earnings per share for the current fiscal year.
The company also recently disclosed a quarterly dividend, which will be paid on Monday, January 15th. Stockholders of record on Tuesday, January 2nd will be given a dividend of $0.4624 per share. The ex-dividend date is Friday, December 29th. This represents a $1.85 annualized dividend and a dividend yield of 3.07%. Cardinal Health’s dividend payout ratio (DPR) is currently 53.78%.
Cardinal Health Company Profile
Cardinal Health, Inc is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also operates nuclear pharmacies and cyclotron facilities; provides pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers, and provides services to healthcare companies.
Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAH).
Receive News & Ratings for Cardinal Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health Inc. and related companies with MarketBeat.com's FREE daily email newsletter.